1. Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.
- Author
-
Klinger, G., Frankenthal, D., Merlob, P., Diamond, G., Sirota, L., Levinson-Castiel, R., Linder, N., Stahl, B., and Inbar, D.
- Subjects
DEVELOPMENTAL disabilities ,BEHAVIOR disorders ,ACADEMIC medical centers ,ANALYSIS of variance ,CEPHALOMETRY ,STATISTICAL correlation ,DENVER Developmental Screening Test ,FISHER exact test ,LONGITUDINAL method ,MATERNAL-fetal exchange ,EVALUATION of medical care ,RESEARCH funding ,SEROTONIN uptake inhibitors ,STATISTICS ,T-test (Statistics) ,LOGISTIC regression analysis ,ENVIRONMENTAL exposure ,CASE-control method ,NEONATAL abstinence syndrome ,DATA analysis software ,DISEASE risk factors ,DISABILITIES - Abstract
Objective:To assess the long-term neurodevelopment of children exposed in utero to selective serotonin reuptake inhibitors (SSRIs) that developed a neonatal abstinence syndrome (NAS).Study Design:Neurodevelopmental evaluation was performed at the age of 2 to 6 years. Children who developed NAS were compared with those who did not using univariate and logistic regression analyses.Result:Thirty children with NAS and 52 without NAS participated in the study. Both groups were similar in mean cognitive ability (106.9±14.0 vs 100.5±14.6, P=0.12) and developmental scores (98.9±11.4 vs 95.7±9.9, P=0.21). However, there was a trend towards small head circumference in the NAS group (20 vs 6%, P=0.068). NAS was associated with an increased risk of social-behavior abnormalities (odds ratio (OR) 3.03, 95% confidence interval (CI) 1.07 to 8.60, P=0.04) and advanced maternal age (OR 1.12, 95% CI 1.00 to 1.25, P=0.04).Conclusion:Infants who developed NAS had normal cognitive ability, but were at an increased risk for social-behavioral abnormalities. Follow-up evaluation of symptomatic neonates should be considered. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF